Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating

Jessica Denning, Jenny Negus, Niamh Cullen

Source: Breathe, 17 (4) 210145; 10.1183/20734735.0145-2021
Journal Issue: December

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jessica Denning, Jenny Negus, Niamh Cullen. Patient experiences of biologic treatment for severe asthma: the good, the outstanding and the deeply frustrating. Breathe, 17 (4) 210145; 10.1183/20734735.0145-2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Balancing treatment and side-effects in severe asthma: a patient and professional perspective
Source: Breathe, 17 (2) 210045; 10.1183/20734735.0045-2021
Year: 2021



What matters to people with severe asthma? Exploring add-on asthma medication and outcomes of importance
Source: ERJ Open Res, 7 (1) 00497-2020; 10.1183/23120541.00497-2020
Year: 2021



Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005

Patients' experiences of asthma exacerbation and management: a qualitative study of severe asthma
Source: ERJ Open Res, 7 (2) 00528-2020; 10.1183/23120541.00528-2020
Year: 2021



"It‘s like living with a time bomb"– European patients‘ perspective on severe asthma symptoms
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005


Problematic severe asthma in children, not one problem but many: a GA2LEN initiative
Source: Eur Respir J 2010; 36: 196-201
Year: 2010



One year following a real life experience of omalizumab for moderate to severe persistent allergic asthma in Malta
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations?
Source: Eur Respir J 2005; 26: Suppl. 49, 310s
Year: 2005

Does better communication produce desired patient outcomes?
Source: Annual Congress 2007 - Making consultations more effective
Year: 2007


A survey of specialist opinions on biomarker use in severe asthma in Australia: scepticism but hope?
Source: ERJ Open Res, 6 (2) 00113-2020; 10.1183/23120541.00113-2020
Year: 2020



Examining the unmet need in adults with severe asthma
Source: Eur Respir Rev 2007; 16: 67-72
Year: 2007



Safeguarding concerns are common in children with problematic severe asthma
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Are there special psychological features in familyes of children with different asthma severity?
Source: Eur Respir J 2003; 22: Suppl. 45, 498s
Year: 2003

What is the optimal management option for occupational asthma?
Source: Eur Respir Rev 2012; 21: 97-104
Year: 2012



Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

A different disease, many diseases or mild asthma gone bad? Challenges of severe asthma
Source: Eur Respir J 2003; 22: 397-398
Year: 2003


How is difficult asthma managed?
Source: Eur Respir J 2006; 28: 968-973
Year: 2006



Helping patients understand what has been communicated to them
Source: Annual Congress 2007 - Making consultations more effective
Year: 2007


How does severe asthma impact on everyday life?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019